Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States
References (20)
- et al.
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004
Am J Kidney Dis
(2007) - et al.
A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan
Diabetes Res Clin Pract
(2007) Chronic kidney disease
- et al.
Chronic kidney disease: Definition and classification
Diabetes and chronic kidney disease: Stages 1–4
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
Am J Kidney Dis
(2002)- et al.
Prevalence of chronic kidney disease in the United States
JAMA
(2007) - et al.
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
Ann Intern Med
(1999) - et al.
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate [published correction appears in Ann Intern Med. 2008;149:519]
Ann Intern Med
(2006) National health and nutrition examination survey codebook for data production (2005–2006)
There are more references available in the full text version of this article.
Cited by (115)
Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
2021, Endocrine and Metabolic ScienceCitation Excerpt :This also explains higher weight gain in ACCORD trial where there were more HEs. Renal disease is the most frequent T2DM complication and affects pharmacokinetic and pharmacodynamic profile of glucose-lowering agents (Bilous, 2008; Gross et al., 2005; Koro et al., 2009). Thus, preventing renal complications is one of the major concerns of T2DM pharmacotherapy.
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study
2020, American Journal of Kidney DiseasesEfficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis
2018, Diabetes Research and Clinical PracticeA cost-effectiveness analysis of linagliptin add-on to insulin treatment for patients with type 2 diabetes mellitus and chronic kidney disease in Iran
2023, Journal of Diabetes and Metabolic Disorders
Copyright © 2009 Excerpta Medica Inc. All rights reserved.